LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 104 filers reported holding LEXICON PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $412,784 | +26.9% | 378,701 | +166.7% | 0.00% | – |
Q2 2023 | $325,194 | -11.7% | 142,006 | -6.3% | 0.00% | – |
Q1 2023 | $368,128 | +23.6% | 151,493 | -2.8% | 0.00% | – |
Q4 2022 | $297,780 | -20.4% | 155,906 | +0.2% | 0.00% | – |
Q3 2022 | $374,000 | -7.4% | 155,643 | -28.3% | 0.00% | – |
Q2 2022 | $404,000 | -11.0% | 217,197 | 0.0% | 0.00% | – |
Q1 2022 | $454,000 | -46.5% | 217,197 | +0.8% | 0.00% | – |
Q4 2021 | $849,000 | -71.1% | 215,541 | -11.8% | 0.00% | -100.0% |
Q2 2018 | $2,934,000 | +3.9% | 244,516 | -25.8% | 0.00% | 0.0% |
Q1 2018 | $2,823,000 | -13.3% | 329,429 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $3,255,000 | +125.9% | 329,429 | +181.0% | 0.00% | – |
Q3 2017 | $1,441,000 | -64.1% | 117,255 | -58.1% | 0.00% | -100.0% |
Q1 2017 | $4,013,000 | +15.2% | 279,874 | +11.1% | 0.00% | 0.0% |
Q4 2016 | $3,484,000 | -23.4% | 251,910 | +0.0% | 0.00% | 0.0% |
Q3 2016 | $4,550,000 | +32.6% | 251,806 | +5.3% | 0.00% | 0.0% |
Q2 2016 | $3,432,000 | – | 239,177 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ulys, L.L.C. | 4,321,214 | $71,084,000 | 100.00% |
Artal Group S.A. | 57,517,977 | $946,170,000 | 16.53% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $587,000 | 1.74% |
SECTOR GAMMA AS | 622,655 | $10,243,000 | 1.49% |
NEA Management Company, LLC | 2,382,286 | $39,189,000 | 1.43% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 606,410 | $9,975,000 | 0.68% |
MOODY ALDRICH PARTNERS LLC | 30,930 | $509,000 | 0.64% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 499,200 | $8,212,000 | 0.56% |
USS Investment Management Ltd | 3,507,900 | $57,705,000 | 0.54% |
Rock Springs Capital Management LP | 393,500 | $6,473,000 | 0.33% |